Prevention of type 2 diabetes: Risk status, clinic, and community

Journal of General Internal Medicine

Volumn 25, Issue 2, 2010, Pages 154-157

  Narayan, K M Venkat ^a   Williamson, David F ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Cost effectiveness; Diabetes; Glycemic status; Prevention

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN;

CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMMUNITY PROGRAM; DIABETIC DIET; DIAGNOSTIC TEST; DIET RESTRICTION; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HEALTH ECONOMICS; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; LIFESTYLE MODIFICATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PUBLIC HEALTH SERVICE; SHORT SURVEY; WEIGHT REDUCTION;

ATTITUDE TO HEALTH; COST-BENEFIT ANALYSIS; DIABETES MELLITUS, TYPE 2; HUMANS; PREDIABETIC STATE; RESIDENCE CHARACTERISTICS; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 77951125995     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-1148-9     Document Type: Short Survey

References (39)

1. EP Joslin 1921 The prevention of diabetes mellitus JAMA 76 79 84
2. J Tuomilehto J Lindström JG Eriksson TT Valle H Ämalainen P Lanne-Parikka, et al. 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 344 1343 1350 10.1056/NEJM200105033441801 1:STN:280:DC%2BD3M3kvFejsA%3D%3D 11333990 (Pubitemid 32378388)
3. WC Knowler E Barrett-Connor SE Fowler RF Hamman JM Lachin EA Walker, et al. 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin New Engl J Med 346 393 403 10.1056/NEJMoa012512 1:CAS:528:DC%2BD38XhtVWqurc%3D 11832527 (Pubitemid 34437694)
4. JC Florez KA Jablonski N Bayley TI Pollin PI de Bakker AR Shuldiner, et al. 2006 TCF7L2 polymorphisms and progression to diabetes in the diabetes prevention program New Engl J Med 355 241 250 10.1056/NEJMoa062418 1:CAS:528:DC%2BD28XntVWktrw%3D 16855264 (Pubitemid 44079339)
5. Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF, Goldstein BJ, et al. The Association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. J Clin Endocrinol Metab. 2008 Nov 18. [Epub ahead of print]
6. The Diabetes Prevention Program Research Group 2005 Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program Diabetes Care 28 888 894 10.2337/diacare.28.4.888 (Pubitemid 40434491)
7. JP Crandall WC Knowler SE Kahn D Marrero JC Florez GA Bray, et al. 2008 The prevention of type 2 diabetes Nature Clinical Practice Endocrinology & Metabolism 4 382 393 10.1038/ncpendmet0843 (Pubitemid 351881862)
8. American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases 2004 Prevention or delay of type 2 diabetes Diabetes Care 27 Suppl 1 S47 S54
9. L Jackson 2009 Translating the diabetes prevention program into practice: a review of community interventions Diabetes Educ 35 309 10.1177/ 0145721708330153 19321809
10. HA Amundson MK Butcher D Gohdes TO Hall, et al. 2009 Translating the diabetes prevention program into practice in the general community: findings from the montana cardiovascular disease and diabetes prevention programs Diabetes Educ 35 209 10.1177/0145721709333269 19321807
11. KM McTigue MB Conroy L Bigi C Murphy M McNeil 2009 Weight loss through living well: Translating an effective lifestyle intervention into clinical practice Diabetes Educ 35 199 10.1177/0145721709332815 19321806
12. American Diabetes Association 2004 Screening for type 2 diabetes Diabetes Care 27 Suppl. 1 S11 S14
13. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999 (WHO/NCD/NCS/99.2).
14. Li Guangwei P Zhang J Wang EW Gregg W Yang Q Gong, et al. 2008 The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study Lancet 371 1783 1789 10.1016/S0140-6736(08)60766-7 (Pubitemid 351697954)
15. J Lindström P Ilanne-Parikka M Peltonen S Aunola JG Eriksson K Hemio, et al. 2006 Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study Lancet 368 1673 1679 10.1016/S0140-6736(06)69701-8 17098085 (Pubitemid 46048554)
16. GA Nichols TA Hillier JB Brown 2008 Normal fasting plasma glucose and risk of type 2 diabetes diagnosis Am J Med 121 519 524 10.1016/j.amjmed.2008.02. 026 1:CAS:528:DC%2BD1cXmt1Ojs7w%3D 18501234 (Pubitemid 351699262)
17. F de Vegt JM Dekker A Jager E Hienkens CDA Stehouwer G Nijpels, et al. 2001 Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn study JAMA 285 2109 2113 10.1001/jama.285.16.2109 11311100
18. Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, et al. Diagnosis, Prognosis, and Treatment of Impaired Glucose Tolerance and Impaired Fasting Glucose. Evidence Report/Technology Assessment No. 128. (Prepared by McMaster University Evidence-based Practice Center under Contract No. 290-02-0020). AHRQ Pub. No 05-E026-2. Rockville, MD: Agency for Healthcare Research and Quality. September 2005.
19. CC Cowie KF Rust ES Ford MS Eberhardt DD Byrd-Hold LI Chaoyang, et al. 2009 Full accounting of diabetes and prediabetes in the US population, 1988-1994 and 2005-2006 Diabetes Care 32 287 294 10.2337/dc08-1296 19017771
20. GD Smith Y Bracha KH Svendsen JD Neaton SM Haffner LH Kuller 2005 Incidence of type 2 diabetes in the randomized multiple risk factor intervention trial Ann Intern Med 142 313 322
21. JS Torgerson J Hauptman MN Boldrin L Sjostrom 2004 Xenical in the prevention of diabetes in obese subjects (XENDOS) study Diabetes Care 27 155 161 10.2337/diacare.27.1.155 1:CAS:528:DC%2BD2cXmvV2jug%3D%3D 14693982 (Pubitemid 38196725)
22. B Richelsen S Tonstad S Rössner S Toubro L Niskanen S Madsbad, et al. 2007 Effect of Orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study Diabetes Care 30 27 32 10.2337/dc06-0210 1:CAS:528:DC%2BD2sXhsFWqtLs%3D 17192328 (Pubitemid 46052496)
23. MC Seidel RO Powell JC Zgibor LM Siminerio GA Platt 2008 Translating the diabetes prevention program into an urban medically underserved community Diabetes Care 31 684 689 10.2337/dc07-1869 18252904
24. Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia. 2008. doi: 10.1007/s00125-008-1038-4.
25. JT Cohen PJ Neumann MC Weinstein 2008 Does preventive care save money? Health economics and the presidential candidates N Engl J Med 358 661 663 10.1056/NEJMp0708558 1:CAS:528:DC%2BD1cXhvVejtbw%3D 18272889 (Pubitemid 351240744)
26. WH Herman TJ Hoerger M Brandle K Hicks S Sorensen P Zhang, et al. 2005 The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance Ann Intern Med 142 323 332 15738451
27. DM Eddy L Schlessinger R Kahn 2005 Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes Ann Intern Med 143 251 264 16103469
28. MW Ealovega BP Tabaei M Brandle R Burke WH Herman 2004 Opportunistic screening for diabetes in routine clinical practice Diab Care 27 9 12 10.2337/diacare.27.1.9 (Pubitemid 38196701)
29. RT Ackermann EA Finch E Brizendine H Zhou DG Marrero 2008 Translating the diabetes prevention program into the community: the DEPLOY pilot study Am J Prev Med 35 4 357 363 10.1016/j.amepre.2008.06.035 18779029
30. KE Heikes DM Eddy B Arondekar L Schlessinger 2008 Diabetes risk calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetes Diabetes Care 31 1040 1045 10.2337/dc07-1150 18070993
31. Brug J. Determinants of healthy eating: motivation, abilities and environmental opportunities. Family Practice 2008. doi: 10.1093/fampra/cmn063.
32. MS Faith KR Fontaine ML Baskin DB Allison 2007 Toward the reduction of population obesity: macrolevel environmental approaches to the problems of food, eating, and obesity Psychol Bull 33 205 226 10.1037/0033-2909.133.2.205
33. M Rahman RK Simmons AH Harding NJ Wareham SJ Griffin 2008 A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study Fam Pract 25 191 196 10.1093/fampra/cmn024 18515811 (Pubitemid 351965938)
34. HS Kahn YJ Cheng TJ Thompson G Imperatore EW Gregg 2009 Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45 to 64 years Ann Intern Med 150 741 751 19487709
35. The International Expert Committee 2009 International expert committee report on the role of the A1C assay in the diagnosis of diabetes Diabetes Care 32 1327 1344 10.2337/dc09-9033
36. Finnish Diabetes Association. Prevention of T2D, FIN-D2D http://www.diabetes.fi/sivu.php?artikkeli-id=1726. Accessed September 18, 2009.
37. Development and Implementation of a European Guideline and Training Standards for Diabetes Prevention (IMAGE). http://www.image-project.eu/Default. aspx?id=1. Accessed September 18, 2009.
38. The National Institute for Health and Welfare, Finland. EU Project DE-PLAN. http://www.ktl.fi/portal/english/research-people-programs/health- promotion-and-chronic-disease-prevention/projects/eu-project-de-plan/ Accessed September 18, 2009.
39. RT Ackermann DG Marrero 2007 Adapting the diabetes prevention program lifestyle intervention for delivery in the community: the YMCA model Diabetes Educ 33 69 78 10.1177/0145721706297743 17272794